https://www.avient.com/sites/default/files/2024-08/AVNT Second Quarter Earnings Press Release.pdf
They use words such as "will," "anticipate," "estimate," "expect,"
"project," "intend," "plan," "believe," and other words and terms of similar meaning in connection
with any discussion of future operating or financial condition, performance and/or sales.
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
June 30, 2024
December 31,
2023
ASSETS
Current assets:
Cash and cash equivalents $ 489.4 $ 545.8
Accounts receivable, net 486.6 399.9
Inventories, net 365.9 347.0
Other current assets 117.2 114.9
Total current assets 1,459.1 1,407.6
Property, net 1,019.9 1,028.9
Goodwill 1,685.1 1,719.3
Intangible assets, net 1,515.7 1,590.8
Other non-current assets 228.0 221.9
Total assets $ 5,907.8 $ 5,968.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 657.7 $ 9.5
Accounts payable 435.2 432.3
Accrued expenses and other current liabilities 405.3 331.8
Total current liabilities 1,498.2 773.6
Non-current liabilities:
Long-term debt 1,420.8 2,070.5
Pension and other post-retirement benefits 63.3 67.2
Deferred income taxes 276.3 281.6
Other non-current liabilities 315.0 437.6
Total non-current liabilities 2,075.4 2,856.9
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,317.5 2,319.2
Noncontrolling interest 16.7 18.8
Total equity 2,334.2 2,338.0
Total liabilities and equity $ 5,907.8 $ 5,968.5
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended
June 30,
2024 2023
Operating Activities
Net income $ 83.5 $ 42.7
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization 88.4 96.2
Accelerated depreciation 0.8 1.9
Share-based compensation expense 9.0 6.5
Changes in assets and liabilities:
Increase in accounts receivable (97.0) (66.6)
(Increase) decrease in inventories (27.3) 14.0
Increase (decrease) in accounts payable 11.9 (26.2)
Taxes paid on gain on sale of business — (103.0)
Accrued expenses and other assets and liabilities, net (6.2) 9.8
Net cash provided (used) by operating activities 63.1 (24.7)
Investing activities
Capital expenditures (55.8) (45.9)
Net proceeds from divestiture — 7.3
Proceeds from plant closures 3.4 —
Other investing activities (2.1) —
Net cash used by investing activities (54.5) (38.6)
Financing activities
Cash dividends paid (47.0) (45.0)
Repayment of long-term debt (4.5) (1.0)
Other financing activities (3.3) (2.3)
Net cash used by financing activities (54.8) (48.3)
Effect of exchange rate changes on cash (10.2) (0.8)
Decrease in cash and cash equivalents (56.4) (112.4)
Cash and cash equivalents at beginning of year 545.8 641.1
Cash and cash equivalents at end of period $ 489.4 $ 528.7
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to
segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not
included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words
and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales.
Whether it’s an ambitious start-up bringing a new product to market, or a large, multi-
national OEM looking for consistency and reliability of global supply, Avient is built for
long-term partnerships.
Investing in Innovation — Specialty companies invest to grow, so we ensure our
resources are concentrated on material science for high-growth end markets, poised for
value creation in the long term.
https://www.avient.com/sites/default/files/2020-09/industrial-springs-application-bulletin2020.pdf
Make the switch to Avient’s thermoset composite
springs, engineered with our proprietary resin/
fiber reinforcement technologies, to achieve long
lasting, consistent performance in a variety of
vibratory conveyor applications:
• High strength-to-weight ratio—less than half
the weight of steel
• Long-term corrosion resistance
• Exceptional fatigue resistance to withstand
billions of cycles
• Deep deflection
• Excellent interlaminar shear strength
• Creep resistance
• Minimal work hardening
• Static electricity control
• Anti-microbial finishes for sanitary
environments
With extensive experience in composite spring
technology, a wide range of rectangular sizes,
and rapid, customized product development
capabilities, we can help you optimize your
industrial equipment for reliable, repeatable,
efficient performance.
https://www.avient.com/sites/default/files/2020-09/composite-furniture-springs-application-bulletin2020.pdf
Make the switch to Avient’s thermoset composite springs,
made with our proprietary resin/fiber reinforcement
technologies, to gain value in a variety
of furniture spring applications:
• Superior overall performance
• Long term corrosion resistance
• High fatigue strength
• Deep deflection
• Excellent inter-laminar shear strength
• Creep resistance
• Minimal work hardening
• Consistent, repeatable cycles for a lifetime
of use
With extensive experience in composite spring
technology, a wide range of rectangular sizes, and rapid,
customized product development capabilities, we can
help you create durable, reliable and cost-effective
furniture for indoor or outdoor use.
https://www.avient.com/sites/default/files/2020-08/composite-braces-case-study.pdf
The composite parts held
up well, and passed stringent standards for long-term
performance.
https://www.avient.com/sites/default/files/2023-03/Therma-Tech Heat Sink for Auto Lights Case Study.pdf
Switching materials from a metal to a polymer carries
large and potentially costly risks in terms of both
performance and production, so Avient Design was
consulted to help alleviate these concerns.
https://www.avient.com/sites/default/files/2022-09/Additives and Colorants for Stadium and Arena Seats Application Bulletin.pdf
UV STABILIZER/COLOR COMBINATIONS
• Combines color and UV stabilization for use
in PP and PA
• Ingredients screened with accelerated
weather testing*
• Excellent weather resistance properties
(against chalking, embrittlement)
• Long-term colorfastness and light stability
UV STABILIZER/FLAME RETARDANT/
COLOR COMBINATIONS
• Combines low halogen flame retardants,
UV stabilizers and color for use in PP and PA
• Ingredients screened with accelerated
weather testing*
• Excellent weather resistance properties
(against chalking, embrittlement)
• Compliant with local fire standards (e.g.:
AFNOR M 2 in France, DIN 4102 B 2–B 1 in
Germany, UNI 8457–9174 C 1 in Italy, BKZ 5.2
in Switzerland, BS 5852.1990 CRIB 3–5 in UK)**
• Standard portfolio available for PP injection
molded applications
APPLICATION BULLETIN
* Laboratory weathering testing may not be determinative of all conditions of use;
the end user must determine suitability of a product for its intended use
** Contact us for more information on regulatory compliance
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2022-12/Cesa Fiber Additives Antimicrobials Product Bulletin.pdf
The additive concentrates are highly
recommended for applications requiring long-term
protection in textiles made of PP, PET, and PA.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.